Research Article
Discrepancies Between Bayesian Vancomycin Models Can Affect Clinical Decisions in the Critically Ill
Table 2
Agreement between models at decision cut-offs.
| | | AUC24 mg⋅h/L | <400 n (%) | 400–600 n (%) | >600 n (%) | Total |
| | Agreement = 59% (273/466) | | | | Goti | | | Colin | <400 | 75 (16) | 5 (1) | 0 (0) | 80 | | 400–600 | 63 (14) | 122 (26) | 10 (2) | 195 | | >600 | 2 (<1) | 113 (24) | 76 (16) | 191 | | | Total | 140 | 240 | 86 | 466 |
| | Agreement = 68% (318/466) | | | | Goti | | | Thomson | <400 | 89 (19) | 14 (3) | 0 (0) | 103 | | 400–600 | 46 (10) | 159 (34) | 16 (3) | 221 | | >600 | 5 (1) | 67 (14) | 70 (15) | 142 | | | Total | 140 | 240 | 86 | 466 |
| | Agreement = 67% (314/466) | | | | Colin | | | Thomson | <400 | 67 (14) | 34 (7) | 2 (<1) | 103 | | 400–600 | 13 (3) | 133 (29) | 75 (16) | 221 | | >600 | 0 (0) | 28 (6) | 114 (24) | 191 | | | Total | 80 | 195 | 191 | 466 |
|
|
